msaustralia.org.au
PBS access to two vital MS treatments under threat as Government decision looms - MS Australia
Multiple disease-modifying therapies (DMTs), Ocrevus (ocrelizumab) and Kesimpta (ofatumumab), are at risk of being withdrawn from the Pharmaceutical Benefits Scheme (PBS), as a consequence of governme...